Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation

NCT05571111 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Based on company decision to close the project. No trial participants received any study drug.

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals